Annual medical spending attributable to obesity: payer-and service-specific estimates.

  title={Annual medical spending attributable to obesity: payer-and service-specific estimates.},
  author={Eric Andrew Finkelstein and Justin G. Trogdon and Joel W. Cohen and William Dietz},
  journal={Health affairs},
  volume={28 5},
In 1998 the medical costs of obesity were estimated to be as high as $78.5 billion, with roughly half financed by Medicare and Medicaid. [] Key Result We found that the increased prevalence of obesity is responsible for almost $40 billion of increased medical spending through 2006, including $7 billion in Medicare prescription drug costs. We estimate that the medical costs of obesity could have risen to $147 billion per year by 2008.

State‐ and Payer‐Specific Estimates of Annual Medical Expenditures Attributable to Obesity

The goal of this study is to expand prior analyses by presenting current state‐level estimates of the costs of obesity in total and separately for Medicare and Medicaid by using the 2006 Medical Expenditure Panel Survey to generate an equation that predicts annual medical expenditures as a function of obesity status.

Severe Obesity In Adults Cost State Medicaid Programs Nearly $8 Billion In 2013.

Efforts to expand Medicaid while controlling spending must be informed by a deeper understanding of the extent to which the high medical costs associated with severe obesity (having a body mass index

Changes in Healthcare Spending Attributable to Obesity: Payer- and Service-Specific Estimates

Current estimates of the effect of obesity on healthcare spending overall, by service line and by payer using the NIH classifications for BMI suggest that persons over BMI of 35 should be the focus for controlling spending.

The External Health-Care Cost of Obesity in the United States

The external cost of obesity, in the form of publicly funded health-care expenditures, and how this cost changes when the distribution of obesity in the population changes is measured.

Changes in healthcare spending attributable to obesity and overweight: payer- and service-specific estimates

While total obesity related spending between 2006 and 2016 was relatively constant, by examining the effect of different obesity classes and overweight, it provides insight into spend for each level of obesity and overweight across service line and payer mix.

The Marginal External Cost of Obesity in the United States

The external cost of obesity, in the form of publicly funded health-care expenditures, and how this cost changes when the distribution of obesity in the population changes is measured.

The costs of obesity and implications for policymakers.

The most recent estimates available in the literature are presented of the per capita and aggregate direct and indirect costs of obesity from an annual and lifetime perspective and the implications for government and employers are discussed.

Medicaid Coverage for Weight Loss Counseling May Make ‘Cents’

It is suggested that coverage of weight-loss counseling programs may be a good investment for Medicaid, and these programs have been shown to be as cost-effective as bariatric surgery and more cost- effective than drug therapy.

Modeling the Economic Cost of Obesity Risk and Its Relation to the Health Insurance Premium in the United States: A State Level Analysis

We propose a new approach for estimating the state-level direct and indirect economic cost of obesity in the United States for the time period 1996 to 2018. Our unique top-down methodology integrates



National medical spending attributable to overweight and obesity: how much, and who's paying?

We use a regression framework and nationally representative data to compute aggregate overweight- and obesity-attributable medical spending for the United States and for select payers. Combined, such

The impact of obesity on rising medical spending.

This work estimates obesity-attributable health care spending increases between 1987 and 2001 and estimates that increases in obesity prevalence alone account for 12 percent of the growth in health spending.

National health spending by medical condition, 1996-2005.

Spending growth rates were lowest for lung cancer, chronic obstructive pulmonary disease, pneumonia, coronary heart disease, and stroke, perhaps reflecting benefits of preventive care.

Reconciling Medical Expenditure Estimates from the MEPS and NHEA, 2002

When MEPS and the NHEA are adjusted to be on a consistent basis, their expenditure estimates differ by 13.8 percent.

A study on the economic impact of bariatric surgery.

Downstream savings associated with bariatric surgery are estimated to offset the initial costs in 2 to 4 years and to have been recouped within 2 years for laparoscopic surgery patients and within 4 years for open surgery patients.

The Department of Health and Human Services.

This letter is in response to your two Citizen Petitions, requesting that the Food and Drug Administration (FDA or the Agency) require a cancer warning on cosmetic talc products.

Behavioral risk factor surveillance system.

By using lessons from the Behavioral Risk Factor Surveillance System, a large, ongoing, state-based surveillance system in the United States, countries may save limited resources, and expedite the initiation of their own surveillance systems.

National health expenditure data overview

    In the 1998 data, MEPS does not include BMI; however, this information was available for a subset of MEPS participants